Stem Cell Banking Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Stem cell banking or preservation is a combined process of extraction, processing and storage of stem cells, so that they may be used for treatment of various medical conditions in the future, when required. Stem cells have the amazing power to get transformed into any tissue or organ in the body. In recent days, stem cells are used to treat variety of life-threatening diseases such as blood and bone marrow diseases, blood cancers, and immune disorders among others.
The market of stem cell banking is anticipated to grow with a significant rate in the coming years, owing to factors such as, development of novel technologies for stem cell preservation and processing, and storage; growing awareness on the potential of stem cells for various therapeutic conditions. Moreover, increasing investments in stem cell research is also expected to propel the growth of the stem cell banking market across the globe. On other hand rising burden of major diseases and emerging economies are expected to offer significant growth opportunities for the players operating in stem cell banking market.
The “Global Stem Cell Banking Market Analysis to 2028” is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The stem cell banking market report aims to provide an overview of global stem cell banking market with detailed market segmentation by source, service type, application, and geography. The global stem cell banking market is expected to witness high growth during the forecast period. The stem cell banking market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global stem cell banking market is segmented on the basis of source, service type, and application. The source segment includes, placental stem cells (PSCS), dental pulp-derived stem cells (DPSCS), bone marrow-derived stem cells (BMSCS), adipose tissue-derived stem cells (ADSCS), human embryo-derived stem cells (HESCS), and other stem cell sources. Based on service type the market is segmented into, sample processing, sample analysis, sample preservation and storage, sample collection and transportation. Based on application, the market is segmented as, clinical applications, research applications, and personalized banking applications.
The stem cell banking market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stem cell banking market based on source, service type, and application. It also provides market size and forecast till 2028 for overall stem cell banking market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America region is accounted to hold a major share market share of stem cell banking market, owing to the well developed and established technologies in the field of stem cell collection and preservation, rapidly growing number of stem cell transplantation procedures, and increasing public preference for private stem cell banking over public stem cell banks. On the other hand, the Asia-Pacific region is expected to exhibit significant growth over the forecast period, with the majority of growth primarily driven by owing to rising birth rates coupled with increasing prevalence of birth defects, options of paying for stem banking in monthly instalments, and rising power of per capita expenditure on healthcare facilities in this region.
The stem cell banking market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The stem cell banking market report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The stem cell banking market report also includes the profiles of key companies engaged with stem cell banking along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Cordlife, ViaCord (A Subsidiary of PerkinElmer), Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell International, Inc., SMART CELLS PLUS, Vita 34, LifeCell, Global Cord Blood Corporation, CBR Systems, Inc.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. STEM CELL BANKING MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Stem Cell Banking Market - By Source
3.2.2. Stem Cell Banking Market - By Service Type
3.2.3. Stem Cell Banking Market - By Application
3.2.4. Stem Cell Banking Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. STEM CELL BANKING MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. STEM CELL BANKING MARKET - GLOBAL ANALYSIS
5.1. GLOBAL STEM CELL BANKING MARKET OVERVIEW
5.2. GLOBAL STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS
6. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY SOURCE
6.1. OVERVIEW
6.2. SOURCE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. PLACENTAL STEM CELLS (PSCS) MARKET
6.3.1. Overview
6.3.2. Placental Stem Cells (PSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. DENTAL PULP-DERIVED STEM CELLS (DPSCS) MARKET
6.4.1. Overview
6.4.2. Dental Pulp-Derived Stem Cells (DPSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.5. BONE MARROW-DERIVED STEM CELLS (BMSCS) MARKET
6.5.1. Overview
6.5.2. Bone Marrow-Derived Stem Cells (BMSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.6. ADIPOSE TISSUE-DERIVED STEM CELLS (ADSCS) MARKET
6.6.1. Overview
6.6.2. Adipose Tissue-Derived Stem Cells (ADSCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.7. HUMAN EMBRYO-DERIVED STEM CELLS (HESCS) MARKET
6.7.1. Overview
6.7.2. Human Embryo-Derived Stem Cells (HESCS) Market Revenue Forecasts and Analysis (US$ Mn)
6.8. OTHER STEM CELL SOURCES MARKET
6.8.1. Overview
6.8.2. Other Stem Cell Sources Market Revenue Forecasts and Analysis (US$ Mn)
7. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY SERVICE TYPE
7.1. OVERVIEW
7.2. SERVICE TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. SAMPLE PRESERVATION AND STORAGE MARKET
7.3.1. Overview
7.3.2. Sample Preservation and Storage Market Revenue Forecasts and Analysis (US$ Mn)
7.4. SAMPLE ANALYSIS MARKET
7.4.1. Overview
7.4.2. Sample Analysis Market Revenue Forecasts and Analysis (US$ Mn)
7.5. SAMPLE PROCESSING MARKET
7.5.1. Overview
7.5.2. Sample processing Market Revenue Forecasts and Analysis (US$ Mn)
7.6. SAMPLE COLLECTION AND TRANSPORTATION MARKET
7.6.1. Overview
7.6.2. Sample Collection and Transportation Market Revenue Forecasts and Analysis (US$ Mn)
8. STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. CLINICAL APPLICATIONS MARKET
8.3.1. Overview
8.3.2. Clinical Applications Market Revenue Forecasts and Analysis (US$ Mn)
8.3.3. Autoimmune Disorders Market
8.3.3.1. Overview
8.3.3.2. Autoimmune Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.3.4. Hematopoietic Disorders Market
8.3.4.1. Overview
8.3.4.2. Hematopoietic Disorders Market Revenue Forecasts and Analysis (US$ Mn)
8.3.5. Other Diseases Market
8.3.5.1. Overview
8.3.5.2. Other Diseases Market Revenue Forecasts and Analysis (US$ Mn)
8.4. RESEARCH APPLICATIONS MARKET
8.4.1. Overview
8.4.2. Research Applications Market Revenue Forecasts and Analysis (US$ Mn)
8.4.3. Life Science Research Market
8.4.3.1. Overview
8.4.3.2. Life Science Research Market Revenue Forecasts and Analysis (US$ Mn)
8.4.4. Disease Treatment Studies Market
8.4.4.1. Overview
8.4.4.2. Disease Treatment Studies Market Revenue Forecasts and Analysis (US$ Mn)
8.4.5. Drug Discovery Market
8.4.5.1. Overview
8.4.5.2. Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
8.5. PERSONALIZED BANKING APPLICATIONS MARKET
8.5.1. Overview
8.5.2. Personalized Banking Applications Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
9.1. NORTH AMERICA STEM CELL BANKING MARKET OVERVIEW
9.2. NORTH AMERICA STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
9.4. NORTH AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
9.5. NORTH AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5.1. North America Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.5.2. North America Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.6. NORTH AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.7.2. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.7.3. US Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3.1. US Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.3.2. US Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.8.2. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.8.3. Canada Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3.1. Canada Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.3.2. Canada Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
9.9.2. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
9.9.3. Mexico Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3.1. Mexico Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.3.2. Mexico Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
10.1. EUROPE STEM CELL BANKING MARKET OVERVIEW
10.2. EUROPE STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
10.4. EUROPE STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
10.5. EUROPE STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5.1. Europe Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.5.2. Europe Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.6. EUROPE STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.7.2. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.7.3. UK Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3.1. UK Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.3.2. UK Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.8.2. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.8.3. Germany Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3.1. Germany Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.3.2. Germany Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
10.9.2. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
10.9.3. France Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3.1. France Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.3.2. France Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC STEM CELL BANKING MARKET OVERVIEW
11.2. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
11.4. ASIA PACIFIC STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
11.5. ASIA PACIFIC STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5.1. Asia Pacific Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.5.2. Asia Pacific Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.6. ASIA PACIFIC STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.7.2. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.7.3. Japan Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3.1. Japan Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.3.2. Japan Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.8.2. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.8.3. China Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3.1. China Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.3.2. China Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
11.9.2. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
11.9.3. India Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3.1. India Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.3.2. India Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5.1. Middle East and Africa (MEA) Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.5.2. Middle East and Africa (MEA) Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.7.2. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.7.3. South Africa Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3.1. South Africa Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.3.2. South Africa Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.8.2. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.8.3. Saudi Arabia Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3.1. Saudi Arabia Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.3.2. Saudi Arabia Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
12.9.2. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
12.9.3. UAE Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3.1. UAE Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.3.2. UAE Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY SOURCE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY SERVICE TYPE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5.1. South and Central America Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.5.2. South and Central America Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA STEM CELL BANKING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Source (US$ Mn)
13.7.2. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Service Type (US$ Mn)
13.7.3. Brazil Stem Cell Banking Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3.1. Brazil Clinical Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.3.2. Brazil Research Applications Market Revenue and Forecasts Analysis - By Type (US$ MN)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. STEM CELL BANKING MARKET, KEY COMPANY PROFILES
15.1. CORDLIFE
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. VIACORD (A SUBSIDIARY OF PERKINELMER)
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. CRYO-SAVE AG
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. STEMCYTE INDIA THERAPEUTICS PVT. LTD.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. CRYO-CELL INTERNATIONAL, INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. SMART CELLS PLUS.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. VITA 34
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. LIFECELL
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. GLOBAL CORD BLOOD CORPORATION
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. CBR SYSTEMS, INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
1. Cordlife
2. ViaCord (A Subsidiary of PerkinElmer)
3. Cryo-Save AG
4. StemCyte India Therapeutics Pvt. Ltd.
5. Cryo-Cell International, Inc.
6. SMART CELLS PLUS.
7. Vita 34
8. LifeCell
9. Global Cord Blood Corporation
10. CBR Systems, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For